Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
January 15, 2021
Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
January 14, 2021
Vor Announces FDA Clearance of IND Application for VOR33
January 13, 2021
Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment
January 11, 2021
IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U.S. FDA
January 11, 2021
Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory Neuropathy
January 6, 2021
Entrada Therapeutics Appoints Dr. Peter Kim to its Board of Directors
January 6, 2021
Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference
January 6, 2021
Artiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO
January 6, 2021
IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor
January 6, 2021
Homology Medicines Announces Plans for Three Clinical Programs in 2021 Spanning Phenylketonuria (PKU) and Hunter Syndrome (MPS II)
« Previous Page
1
…
44
45
46
47
48
…
118
Next Page »